Stay updated on LY3022855 Combo with Immunotherapy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the LY3022855 Combo with Immunotherapy in Solid Tumors Clinical Trial page.

Latest updates to the LY3022855 Combo with Immunotherapy in Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe page revision label was updated from v3.3.3 to v3.3.4, a minor site update. This change does not modify the study content, eligibility criteria, or displayed results for NCT02718911. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedAdded a dedicated Locations section listing study sites in the United States (Colorado, Florida, Georgia, New York, Tennessee) and the Czech Republic. Removed the HHS Vulnerability Disclosure footer link.SummaryDifference0.7%

- Check57 days agoChange DetectedAdded a PubMed auto-fill note and updated the revision to v3.3.2, replacing the previous PubMed wording and v3.2.0 tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedRemoved the government funding status notice from the page. This change affects only ancillary page messaging and does not alter study details, eligibility, or results.SummaryDifference0.3%

- Check78 days agoChange DetectedThe new screenshot shows no substantive updates to the study details; only minor layout/UI adjustments are observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check100 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version tag v3.1.0.SummaryDifference3%

Stay in the know with updates to LY3022855 Combo with Immunotherapy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY3022855 Combo with Immunotherapy in Solid Tumors Clinical Trial page.